PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
AxoGen, Inc. (AXGN)
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Company Info

ISIN

US05463X1063

CUSIP

05463X106

Sector

Healthcare

IPO Date

Mar 27, 1990

Highlights

Market Cap

$822.08M

EPS (TTM)

-$0.33

Total Revenue (TTM)

$137.93M

Gross Profit (TTM)

$104.40M

EBITDA (TTM)

$1.22M

Year Range

$5.55 - $19.18

Target Price

$20.83

Short %

5.05%

Short Ratio

3.31

Share Price Chart


Loading data...

Compare to other instruments

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Popular comparisons:
AXGN vs. SPY
Popular comparisons:
AXGN vs. SPY

Performance

Performance Chart

The chart shows the growth of an initial investment of $10,000 in AxoGen, Inc., comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.


0.00%10.00%20.00%30.00%40.00%50.00%SeptemberOctoberNovemberDecember2025February
51.26%
10.30%
AXGN (AxoGen, Inc.)
Benchmark (^GSPC)

Returns By Period

AxoGen, Inc. had a return of 13.35% year-to-date (YTD) and 79.27% in the last 12 months. Over the past 10 years, AxoGen, Inc. had an annualized return of 19.46%, outperforming the S&P 500 benchmark which had an annualized return of 11.31%.


AXGN

YTD

13.35%

1M

3.26%

6M

44.58%

1Y

79.27%

5Y*

4.93%

10Y*

19.46%

^GSPC (Benchmark)

YTD

4.46%

1M

2.46%

6M

9.31%

1Y

23.49%

5Y*

13.03%

10Y*

11.31%

*Annualized

Monthly Returns

The table below presents the monthly returns of AXGN, with color gradation from worst to best to easily spot seasonal factors. Returns are adjusted for dividends.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
202510.50%13.35%
202441.58%9.20%-23.58%-20.57%6.55%6.00%21.27%49.77%6.62%-0.14%-0.71%18.56%141.29%
2023-5.11%-12.88%14.55%-4.55%-5.76%7.41%-5.37%-27.55%-20.13%-24.80%74.20%4.27%-31.56%
2022-7.04%7.23%-14.99%-8.82%33.56%-15.31%13.80%0.54%27.21%-4.19%-4.12%-8.86%6.51%
2021-3.07%27.38%-8.33%-7.60%8.44%6.45%-5.74%-16.25%-7.39%-3.86%-37.00%-2.09%-47.65%
2020-30.91%0.16%-15.99%-6.25%-0.51%-4.74%23.05%4.40%-2.02%8.43%13.32%25.26%0.06%
2019-19.24%11.88%14.08%11.49%-10.86%-5.40%-9.19%-11.85%-21.26%-0.32%39.31%3.23%-12.43%
2018-1.77%5.04%25.00%9.04%23.37%2.34%-10.59%-2.40%-15.96%1.19%-10.22%-38.98%-27.81%
201721.11%-4.13%0.00%16.75%21.72%12.79%-5.67%11.39%9.94%6.20%29.93%5.99%214.44%
2016-0.80%4.84%3.08%8.58%-4.47%23.74%-2.33%34.08%0.22%-1.99%-5.65%7.78%80.00%
2015-4.18%-7.85%10.41%-2.86%-10.00%2.61%9.24%38.48%-13.26%12.86%18.28%-9.09%39.28%
2014-10.24%0.25%-24.50%-16.72%-0.79%10.32%-14.03%6.28%-3.94%13.52%1.81%27.30%-20.04%

Risk-Adjusted Performance

Risk-Adjusted Performance Rank

With an overall rank of 78, AXGN is among the top 22% of stocks on our website when it comes to balancing risk and reward. Below is a breakdown of how it compares using common performance measures.


The Risk-Adjusted Performance Rank of AXGN is 7878
Overall Rank
The Sharpe Ratio Rank of AXGN is 8181
Sharpe Ratio Rank
The Sortino Ratio Rank of AXGN is 8080
Sortino Ratio Rank
The Omega Ratio Rank of AXGN is 7979
Omega Ratio Rank
The Calmar Ratio Rank of AXGN is 7676
Calmar Ratio Rank
The Martin Ratio Rank of AXGN is 7575
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

Risk-Adjusted Performance Indicators

The charts below present risk-adjusted performance metrics for AxoGen, Inc. (AXGN) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.


Sharpe ratio
The chart of Sharpe ratio for AXGN, currently valued at 1.19, compared to the broader market-2.000.002.001.191.74
The chart of Sortino ratio for AXGN, currently valued at 2.05, compared to the broader market-4.00-2.000.002.004.006.002.052.35
The chart of Omega ratio for AXGN, currently valued at 1.27, compared to the broader market0.501.001.502.001.271.32
The chart of Calmar ratio for AXGN, currently valued at 0.87, compared to the broader market0.002.004.006.000.872.61
The chart of Martin ratio for AXGN, currently valued at 3.65, compared to the broader market0.0010.0020.0030.003.6510.66
AXGN
^GSPC

The current AxoGen, Inc. Sharpe ratio is 1.19. This value is calculated based on the past 1 year of trading data and takes into account price changes and dividends.

Use the chart below to compare the Sharpe ratio of AxoGen, Inc. with the selected benchmark, providing insights into the investment's historical performance in terms of risk-adjusted returns. Go to the Sharpe ratio tool for more fine-grained control over the calculation options.


Rolling 12-month Sharpe Ratio1.001.502.002.503.003.504.00SeptemberOctoberNovemberDecember2025February
1.19
1.74
AXGN (AxoGen, Inc.)
Benchmark (^GSPC)

Dividends

Dividend History


AxoGen, Inc. doesn't pay dividends

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.


-80.00%-60.00%-40.00%-20.00%0.00%SeptemberOctoberNovemberDecember2025February
-66.58%
0
AXGN (AxoGen, Inc.)
Benchmark (^GSPC)

Worst Drawdowns

The table below displays the maximum drawdowns of the AxoGen, Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the AxoGen, Inc. was 98.50%, occurring on Aug 16, 2002. Recovery took 3701 trading sessions.

The current AxoGen, Inc. drawdown is 66.58%.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-98.5%Jun 10, 19961558Aug 16, 20023701May 1, 20175259
-93.54%Jul 24, 20181329Nov 1, 2023
-52.46%Aug 28, 1991169Apr 28, 1992750Apr 17, 1995919
-42.86%Apr 30, 1990183Jan 17, 199141Mar 18, 1991224
-40.35%Apr 19, 1995112Sep 26, 1995176Jun 6, 1996288

Volatility

Volatility Chart

The current AxoGen, Inc. volatility is 10.37%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.


0.00%5.00%10.00%15.00%20.00%25.00%30.00%35.00%SeptemberOctoberNovemberDecember2025February
10.37%
3.07%
AXGN (AxoGen, Inc.)
Benchmark (^GSPC)

Financials

Financial Performance

The chart below illustrates the trends in the financial health of AxoGen, Inc. over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.

Annual
Quarterly

0.0

Historical P/E Ratio Chart

The chart below displays the historical trend of the price-to-earnings (P/E) ratio for AxoGen, Inc..


Loading data...

Income Statement



TTM
Revenue

Total Revenue

Cost Of Revenue

Gross Profit

Operating Expenses

Selling, General & Admin Expenses

R&D Expenses

Depreciation And Amortization

Total Operating Expenses

Income

Income Before Tax

Operating Income

EBITDA

EBIT

Earnings From Continuing Operations

Net Income

Income Tax Expense

Other Non-Operating Income (Expenses)

Extraordinary Items

Discontinued Operations

Effect Of Accounting Charges

Non Recurring

Minority Interest

Other Items

Interest Income

Interest Expense

Net Interest Income

Values in undefined except per share items
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2025 PortfoliosLab